These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17372541)

  • 1. [Heritability and candidate genes in tobacco use].
    Hamdani N; Ades J; Gorwood P
    Encephale; 2006; 32(6 Pt 1):966-75. PubMed ID: 17372541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetics of nicotine dependence: relationship to pancreatic cancer.
    MacLeod SL; Chowdhury P
    World J Gastroenterol; 2006 Dec; 12(46):7433-9. PubMed ID: 17167830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene-gene interactions of CYP2A6 and MAOA polymorphisms on smoking behavior in Chinese male population.
    Tang X; Guo S; Sun H; Song X; Jiang Z; Sheng L; Zhou D; Hu Y; Chen D
    Pharmacogenet Genomics; 2009 May; 19(5):345-52. PubMed ID: 19415821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic influence of dopamine receptor, dopamine transporter, and nicotine metabolism on smoking cessation and nicotine dependence in a Japanese population.
    Ohmoto M; Takahashi T; Kubota Y; Kobayashi S; Mitsumoto Y
    BMC Genet; 2014 Dec; 15():151. PubMed ID: 25526961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence.
    Malaiyandi V; Sellers EM; Tyndale RF
    Clin Pharmacol Ther; 2005 Mar; 77(3):145-58. PubMed ID: 15735609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics and smoking behavior.
    Schnoll RA; Johnson TA; Lerman C
    Curr Psychiatry Rep; 2007 Oct; 9(5):349-57. PubMed ID: 17915073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation.
    Kubota T; Nakajima-Taniguchi C; Fukuda T; Funamoto M; Maeda M; Tange E; Ueki R; Kawashima K; Hara H; Fujio Y; Azuma J
    Pharmacogenomics J; 2006; 6(2):115-9. PubMed ID: 16402086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically decreased CYP2A6 and the risk of tobacco dependence: a prospective study of novice smokers.
    O'Loughlin J; Paradis G; Kim W; DiFranza J; Meshefedjian G; McMillan-Davey E; Wong S; Hanley J; Tyndale RF
    Tob Control; 2004 Dec; 13(4):422-8. PubMed ID: 15564629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A common genetic defect in nicotine metabolism decreases risk for dependence and lowers cigarette consumption.
    Tyndale RF; Pianezza ML; Sellers EM
    Nicotine Tob Res; 1999; 1 Suppl 2():S63-7; discussion S69-70. PubMed ID: 11768189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP2A6, MAOA, DBH, DRD4, and 5HT2A genotypes, smoking behaviour and cotinine levels in 1518 UK adolescents.
    Huang S; Cook DG; Hinks LJ; Chen XH; Ye S; Gilg JA; Jarvis MJ; Whincup PH; Day IN
    Pharmacogenet Genomics; 2005 Dec; 15(12):839-50. PubMed ID: 16272956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking behavior and related cancers: the role of CYP2A6 polymorphisms.
    Nakajima M
    Curr Opin Mol Ther; 2007 Dec; 9(6):538-44. PubMed ID: 18041664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of the pharmacogenomics of cigarette smoking.
    Ho MK; Tyndale RF
    Pharmacogenomics J; 2007 Apr; 7(2):81-98. PubMed ID: 17224913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of CYP2A6 in the emergence of nicotine dependence in adolescents.
    Audrain-McGovern J; Al Koudsi N; Rodriguez D; Wileyto EP; Shields PG; Tyndale RF
    Pediatrics; 2007 Jan; 119(1):e264-74. PubMed ID: 17130279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are serotonergic system genes associated to smoking cessation therapy success in addition to CYP2A6?
    Verde Z; Santiago C; Rodríguez González-Moro JM; de Lucas Ramos P; López Martín S; Bandrés F; Lucia A; Gómez-Gallego F
    Pharmacopsychiatry; 2014 Jan; 47(1):33-6. PubMed ID: 24127329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analytic review of the CYP2A6 genotype and smoking behavior.
    Carter B; Long T; Cinciripini P
    Nicotine Tob Res; 2004 Apr; 6(2):221-7. PubMed ID: 15203795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An association of CYP2A6 genotype and smoking topography.
    Strasser AA; Malaiyandi V; Hoffmann E; Tyndale RF; Lerman C
    Nicotine Tob Res; 2007 Apr; 9(4):511-8. PubMed ID: 17454707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP2A6 gene polymorphism and personality traits for NEO-FFI on the smoking behavior of youths.
    Waga C; Iwahashi K
    Drug Chem Toxicol; 2007; 30(4):343-9. PubMed ID: 17934923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genetic determinants of smoking.
    Batra V; Patkar AA; Berrettini WH; Weinstein SP; Leone FT
    Chest; 2003 May; 123(5):1730-9. PubMed ID: 12740294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics of alcohol and tobacco use in humans.
    Tyndale RF
    Ann Med; 2003; 35(2):94-121. PubMed ID: 12795339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoking cessation program and CYP2A6 polymorphism.
    Ozaki S; Oyama T; Isse T; Kagawa N; Uramoto H; Sugio K; Yasumoto K; Kono K; Kawamoto T
    Front Biosci; 2006 Sep; 11():2590-7. PubMed ID: 16720336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.